Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$43.99 USD

43.99
1,464,930

+0.82 (1.90%)

Updated May 27, 2022 04:00 PM ET

After-Market: $43.98 -0.01 (-0.02%) 5:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.08%
2Buy18.56%
3Hold10.15%
4Sell5.79%
5Strong Sell2.83%
S&P50011.24%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (67 out of 253)

Industry: Chemical - Diversified

Trades from $1

Zacks News

Is Chemours (CC) Outperforming Other Basic Materials Stocks This Year?

Here is how Chemours (CC) and Gerdau (GGB) have performed compared to their sector so far this year.

Chemours (CC) is a Great Momentum Stock: Should You Buy?

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Chemours (CC) Declares New Process for APA Grade Viton Production

Chemours (CC) now has the potential to produce the complete Viton fluoroelastomers portfolio using a non-fluorinated surfactant.

Chemours (CC) Stock Pops 44% in 3 Months: What's Driving It?

Chemours (CC) is benefiting from strong end-market demand and its cost-reduction and pricing actions.

Zacks Industry Outlook Highlights Dow, Albemarle, Huntsman and The Chemours

Dow, Albemarle, Huntsman and The Chemours have been highlighted in this Industry Outlook article.

Anindya Barman headshot

4 Stocks to Buy From the Promising Diversified Chemical Industry

An upswing in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. DOW, ALB, HUN and CC are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.

Is Chemours (CC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks.com featured highlights include Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA

Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA are part of Screen of the Week article.

Rimmi Singhi headshot

5 High Earnings Yield Value Picks Amid Market Jitters

Value investing should be one of the most effective investment approaches now. IMO, CF, CC, MED and APA are some high earnings yield value stocks to tide over market mayhem.

The Zacks Analyst Blog Highlights Penske Automotive Group, Griffon, Louisiana-Pacific, The Chemours, and Avnet

Penske Automotive Group, Griffon, Louisiana-Pacific, The Chemours, and Avnet are part of Zacks top Analyst Blog.

Is Chemours (CC) a Great Stock for Value Investors?

Is Chemours (CC) a great pick from the value investor's perspective right now? Read on to know more.

Nalak Das headshot

5 Must-Buy Mid Cap Winners of Past Month With More Upside

We have narrowed our search to five mid-cap stocks that have popped double-digit in the past month, with more upside. These are: LPX, GFF, PAG, CC and AVT.

Are Basic Materials Stocks Lagging Carpenter Technology (CRS) This Year?

Here is how Carpenter Technology (CRS) and Chemours (CC) have performed compared to their sector so far this year.

Chemours (CC) Shows Fast-paced Momentum But Is Still a Bargain Stock

Chemours (CC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Chemours (CC) Earnings and Revenues Top Estimates in Q1

Chemours (CC) gains on strong volumes and higher prices amid headwinds from raw material cost inflation and logistics challenges in Q1.

Chemours (CC) Q1 Earnings and Revenues Beat Estimates

Chemours (CC) delivered earnings and revenue surprises of 58.70% and 14.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Scotts Miracle-Gro (SMG) to Post Q2 Earnings: What's in Store?

ScottsMiracle-Gro's (SMG) Q2 performance is likely to have benefited from strength in the U.S. Consumer segment and cost savings.

Andersons (ANDE) to Report Q1 Earnings: What's in the Offing?

Andersons's (ANDE) Q1 performance is likely to reflect benefits from strong demand and high commodity and fertilizer prices.

TimkenSteel (TMST) to Report Q1 Earnings: What's in the Cards?

TimkenSteel (TMST) is expected to have benefited, in the first quarter, from higher demand in industrial and energy end markets.

DuPont (DD) Gears Up for Q1 Earnings: What's in the Offing?

DuPont (DD) is likely to have benefited from strong demand and productivity actions. However, higher raw material and logistics costs are expected to have hurt its Q1 results.

Why Chemours (CC) Might Surprise This Earnings Season

Chemours (CC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Will Higher Prices Benefit Nutrien (NTR) in Q1 Earnings?

Higher prices aided by strong demand and tight supply are likely to have driven Nutrien's (NTR) sales and margins in the first quarter.

FMC Corp (FMC) to Post Q1 Earnings: What's in the Cards?

FMC Corp's (FMC) first-quarter performance is likely to reflect increased demand and pricing amid headwinds from higher input costs resulting from supply chain disruptions.

Westlake (WLK) to Post Q1 Earnings: What's in the Cards?

Westlake's (WLK) Q1 performance is likely to have benefited from higher demand trends for polyethylene and PVC resin.